Previous 10 | Next 10 |
Losers: Leap Therapeutics (NASDAQ: LPTX ) +49% . More news on: Leap Therapeutics, Inc., Yuma Energy, Inc., Inpixon, Stocks on the move, Read more ...
Novan (NASDAQ: NOVN ) -73% on failed SB206 study. More news on: Novan, Inc., DPW Holdings, Inc., Landec Corporation, Stocks on the move, Read more ...
Gainers: Inpixon (NASDAQ: INPX ) +125% . More news on: Inpixon, Synthesis Energy Systems, Inc., Trillium Therapeutics Inc., Stocks on the move, Read more ...
Synthesis Energy Systems (NASDAQ: SES ) +83% . More news on: Synthesis Energy Systems, Inc., Recon Technology, Ltd., Cassava Sciences, Inc., Stocks on the move, Read more ...
Some Of The Top Penny Stocks To Watch On Monday Penny stocks are perhaps some of the most sought after stocks in the market for those looking to make quick money. The reason behind that lies in the fact that these cheap stocks allow investors to make a substantial return even if the stock mo...
Trillium Therapeutics (NASDAQ: TRIL ): 9M GAAP EPS of -C$1.23. More news on: Trillium Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
TORONTO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today reported financial results for th...
TORONTO, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that new preclinical data from its STING agonist program will be presented at the...
Aimed at extending its cash runway while it sharpens its focus on shareholder value-boosting activities, Trillium Therapeutics ( TRIL -5% ) initiates a restructuring initiative that includes a 40% reduction in jobs from 43 to 26. More news on: Trillium Therapeutics Inc., Healthcare sto...
TORONTO, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Trillium, "the company") (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced corporate restructuring to extend the company’s ...
News, Short Squeeze, Breakout and More Instantly...
Trillium Therapeutics Inc. Company Name:
TRIL Stock Symbol:
NASDAQ Market:
Trillium Therapeutics Inc. Website:
The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substance...
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributors Keith Speights and Brian Orelli explain why the news of a discontinued drug from the pharmaceutical giant hasn't shaken investors. Keith Speights: Pf...
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce...